Region 7 Healthcare Coalition
  • Home
    • Important Links
    • Public Health Emergency
    • State of Michigan
  • About
    • Region 7 Staff
  • Events
  • News Room
    • Newsletter
    • Blog
  • Partners
    • Partner Resources
  • Contact
    • Feedback

Alerts

Updated MDHHS Zika Virus Testing Guidance for Healthcare Providers - August 3, 2016

8/9/2016

 
​Message Details
Date Sent: 08/03/2016 04:47 PM EDT
Sender: Michigan Health Alert Network
Subject: Updated MDHHS Zika Virus Testing Guidance for Healthcare Providers - August 3, 2016


Message:
The CDC has recently issued updated guidance for healthcare providers caring for Pregnant Women with Possible Zika Virus Exposure and Prevention of Sexual Transmission.  In addition, limited local transmission of Zika virus has recently been identified in an area of Miami, Florida.  As a result, MDHHS has updated the guidance provided to Michigan healthcare providers in a Memo dated May 6, 2016 regarding specimens that will be accepted for Zika virus testing of patients in Michigan.  The updated guidance is as follows:
Criteria for Diagnostic Testing of Potentially Exposed Individuals
Testing is currently indicated for the following individuals:
  • Pregnant women who have:
    • History of travel to an area with ongoing Zika virus transmission*
      • And have clinical illness consistent with Zika virus infection (one or more of the following: fever, rash, joint pain, red irritated eyes) within two weeks of travel
      • Or have no symptoms, and are within 12 weeks after their return from travel
    • Had sex without barrier protection with a partner with possible Zika virus exposure* (neither partner need to be symptomatic)
  • A person who has a clinical illness consistent with Zika virus infection (one or more of the following: fever, rash, joint pain, red irritated eyes) and within two weeks of illness onset and
    • Has a history of travel to an area with ongoing Zika virus transmission* OR
    • May have been exposed to Zika virus through sex without barrier protection with a person who has a history of travel to an area with ongoing Zika virus transmission* 
  • A fetus or infant with suspected or confirmed microcephaly or intracranial calcifications (diagnosed prenatally or at birth) whose mother:
    • Spent time in an area with ongoing Zika virus transmission*
    • During pregnancy, had sex without barrier protection with a partner who spent time in an area with active Zika virus transmission*
  • A person who developed Guillain-Barre syndrome after spending time in an area with active Zika virus transmission*

*Utilize the CDC website for the most current information about areas with active Zika virus transmission both outside and within the U.S.:http://www.cdc.gov/zika/geo/index.html


[At present, Zika virus testing for the assessment of risk for sexual transmission is of uncertain value, because current understanding of the duration and pattern of shedding of Zika virus in the male and female genitourinary tract is limited. Therefore, testing of specimens to assess risk for sexual transmission is currently not recommended.] 


Specimen Requirements for Diagnostic Testing:

  • Serum, urine, or CSF
  • Collect and submit both serum and urine on:
    • All pregnant patients
      • For symptomatic and asymptomatic pregnant patients tested
    • Symptomatic patients within 14 days of their illness onset
  • Amniotic fluid, urine, tissue and other specimens may be submitted to assess the utility of these samples to detect virus, contact MDHHS Epi at 517-335-8165 for instructions on specimen collection and handling
  • All specimens other than serum must be accompanied by a serum sample
For information about submitting specimens to MDHHS BOL, see the specimen collection and submission page athttp://www.michigan.gov/emergingdiseases/0,4579,7-186-77096_77098-377958--,00.html.

How to request Zika testing at MDHHS
:

Healthcare providers must contact their local health department (www.malph.org) to request Zika virus testing for Michigan residents. This process assures that the appropriate tests are ordered and that specimens are correctly collected, labeled, processed, packaged, and transported. Public health agencies will assist providers with deciding on the appropriate test and completing the required forms. Testing may be delayed if specimens are received without prior approval. 
Finally, Zika virus is a reportable condition in Michigan (under “Arboviral” on the list posted athttp://www.michigan.gov/documents/mdch/Reportable_Diseases_Michigan_by_Pathogen_478489_7.pdf). Any healthcare provider or laboratory must report suspect and confirmed cases of Zika virus to the appropriate Michigan local public health department.


--This message is being sent to the following statewide HAN roles: Communicable Disease / Infection Prevention | Epidemiology | HAN Coordinator | Health Officer | Healthcare | Laboratory | Physician / Medical Director--

Comments are closed.

    CDC Alerts

    For Nationwide Alerts, please click on one of the archive links below. 
    2014 Alerts     
    2013 Alerts 
    2012 Alerts     
    ​
    2011 Alerts

    Archives

    August 2017
    July 2017
    May 2017
    April 2017
    January 2017
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    June 2015
    May 2015
    January 2015
    December 2014
    November 2014
    July 2014
    June 2014
    May 2014

    Categories

    All
    Agriculture /Animal Health
    ASPR TRACIE
    Centers For Disease Control
    Children
    Communicable Disease / Infection Prevention
    Communications / Public Information
    Community Health Emergency Coordination Center (CHECC)
    Cyber Security
    Drug Enforcement Administration
    Ebola
    Elderly
    Emergency Management
    Emergency Preparedness
    Emergency Room
    Environmental
    Epidemiology
    FBI
    First Responders
    Food And Drug Administration
    HAN Coordinator
    Health And Human Services (HHS)
    Healthcare
    Health Officer
    Hospital
    Infectious Disease
    Influenza
    Laboratory
    Law Enforcement
    Local Health Department
    Medical Director
    Michigan Department Of Health And Human Services
    Michigan Department Of Health And Human Services
    Michigan Departments Of Agriculture And Rural Development
    Michigan Poison Control Center
    Michigan Regional Poison Center
    National Guard
    Neurology
    Physician
    Pregnancy
    Primary Care
    Public Health
    Public Information Officers
    Recalls
    Reports
    Security/Public Safety/ Military
    State Guidance
    Technology
    US Dept. Of Agriculture
    Vaccines
    Viral Illness
    World Health Organization

    RSS Feed

To activate the Region 7
Medical Coordination Center call:


Gaylord Regional
Communication Center
1-989-732-5141

​

During your call, include the following information: 

- Your name and contact number.
- Your agency or hospital.
- The reason for requesting the resource.
- Exact location to where you need the resource delivered.
- Who will accept and sign for the resource.

Site Map

Home
Important links
Public Health Emergency
Michigan.gov
Events
Newsroom
Alerts
Newsletter
Members
Partner Resources

Organization

About
Blog
Contact
web counter
web counter
R7HCC logo
Copyright © 2014 | 2464 Silver Fox Trail Suite A, Gaylord MI 49735 | 989.748.4975
  • Home
    • Important Links
    • Public Health Emergency
    • State of Michigan
  • About
    • Region 7 Staff
  • Events
  • News Room
    • Newsletter
    • Blog
  • Partners
    • Partner Resources
  • Contact
    • Feedback